Wellington Management Group’s Meridian Bioscience Inc VIVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-30,221
Closed -$1M 2159
2022
Q4
$1M Hold
30,221
﹤0.01% 1634
2022
Q3
$953K Buy
+30,221
New +$979K ﹤0.01% 1667
2022
Q2
Sell
-17,526
Closed -$455K 2237
2022
Q1
$455K Buy
+17,526
New +$417K ﹤0.01% 1940
2021
Q3
Sell
-99,556
Closed -$2.21M 2307
2021
Q2
$2.21M Sell
99,556
-44,783
-31% -$950K ﹤0.01% 1659
2021
Q1
$3.79M Sell
144,339
-256,130
-64% -$6.09M ﹤0.01% 1484
2020
Q4
$7.49M Buy
400,469
+373,369
+1,378% +$6.97M ﹤0.01% 1248
2020
Q3
$460K Buy
+27,100
New +$527K ﹤0.01% 1732
2018
Q4
Sell
-36,128
Closed -$538K 2246
2018
Q3
$538K Hold
36,128
﹤0.01% 2019
2018
Q2
$574K Hold
36,128
﹤0.01% 2000
2018
Q1
$513K Buy
+36,128
New +$535K ﹤0.01% 2018
2017
Q1
Sell
-19,600
Closed -$347K 2329
2016
Q4
$347K Sell
19,600
-15,700
-44% -$276K ﹤0.01% 2069
2016
Q3
$681K Hold
35,300
﹤0.01% 1931
2016
Q2
$688K Hold
35,300
﹤0.01% 1861
2016
Q1
$728K Hold
35,300
﹤0.01% 1883
2015
Q4
$724K Sell
35,300
-13,100
-27% -$251K ﹤0.01% 1900
2015
Q3
$828K Hold
48,400
﹤0.01% 1872
2015
Q2
$902K Hold
48,400
﹤0.01% 1859
2015
Q1
$923K Buy
+48,400
New +$895K ﹤0.01% 1862

Other funds holding VIVO

Wellington Management Group's VIVO Position: Q1 2023 in Review

Wellington Management Group sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 30,221 shares — an estimated $1M sold.

Wellington Management Group first reported a position in VIVO in Q1 2015 and held it in 18 quarters. The position peaked at $7.49M in Q4 2020. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Wellington Management Group reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Wellington Management Group sold 30,221 Meridian Bioscience Inc shares in Q1 2023, an estimated $1M.
  • Wellington Management Group first reported a position in Meridian Bioscience Inc in Q1 2015 and held it in 18 quarters.
  • Wellington Management Group's Meridian Bioscience Inc position peaked at $7.49M in Q4 2020.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Wellington Management Group's 13F filing for Q1 2023, filed 12 May 2023.